↓ Skip to main content

Cochrane Database of Systematic Reviews

Clonidine for smoking cessation

Overview of attention for article published in Cochrane database of systematic reviews, July 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

policy
1 policy source
twitter
1 tweeter
wikipedia
8 Wikipedia pages

Citations

dimensions_citation
165 Dimensions

Readers on

mendeley
134 Mendeley
Title
Clonidine for smoking cessation
Published in
Cochrane database of systematic reviews, July 2004
DOI 10.1002/14651858.cd000058.pub2
Pubmed ID
Authors

Steven G Gourlay, Lindsay F Stead, Neal Benowitz

Abstract

Clonidine was originally used to lower blood pressure. It acts on the central nervous system and may reduce withdrawal symptoms in various addictive behaviours, including tobacco use.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 134 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 1%
United Kingdom 1 <1%
United States 1 <1%
Brazil 1 <1%
Unknown 129 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 14%
Student > Bachelor 19 14%
Student > Master 17 13%
Student > Ph. D. Student 10 7%
Student > Doctoral Student 10 7%
Other 18 13%
Unknown 41 31%
Readers by discipline Count As %
Medicine and Dentistry 47 35%
Nursing and Health Professions 11 8%
Biochemistry, Genetics and Molecular Biology 6 4%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Psychology 5 4%
Other 16 12%
Unknown 43 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2022.
All research outputs
#3,926,883
of 21,738,040 outputs
Outputs from Cochrane database of systematic reviews
#6,418
of 12,099 outputs
Outputs of similar age
#30,923
of 173,017 outputs
Outputs of similar age from Cochrane database of systematic reviews
#41
of 95 outputs
Altmetric has tracked 21,738,040 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,099 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.5. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,017 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.